Bora Pharmaceuticals Co., LTD. (6472.TW)
TWD 695.0
(-3.34%)
TWD 695.0
(-3.34%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 14.2 Billion | 10.49 Billion | 4.89 Billion | 1.79 Billion | 1.52 Billion |
| Cost of Revenue | 7.2 Billion | 7.58 Billion | 3.22 Billion | 1.09 Billion | 886.18 Million |
| Gross Profit | 6.99 Billion | 2.91 Billion | 1.67 Billion | 703.88 Million | 643.03 Million |
| Operating Expenses | 1.74 Billion | 990.59 Million | 625.78 Million | 477.8 Million | 305.59 Million |
| Selling, General and Administrative Expenses | 1.44 Billion | 861.52 Million | 584.52 Million | 441.15 Million | 258.54 Million |
| Research and Development Expenses | 298.16 Million | 129.07 Million | 41.26 Million | 36.65 Million | 39.64 Million |
| Other Expenses | - | 26.55 Million | 31.59 Million | 3.43 Million | - |
| Cost and Expenses | 8.95 Billion | 8.57 Billion | 3.85 Billion | 1.57 Billion | 1.19 Billion |
| Operating Income | 5.24 Billion | 1.94 Billion | 1.07 Billion | 229.51 Million | 344.84 Million |
| Interest Expense | 171.23 Million | 108.72 Million | 53.61 Million | 21.97 Million | 14.53 Million |
| Income Tax Expense | 992.22 Million | 438.47 Million | 274.23 Million | 16.97 Million | 20.31 Million |
| Earnings before Tax | 4.06 Billion | 1.84 Billion | 1.02 Billion | 595.39 Million | 325.35 Million |
| Net Income | 3.03 Billion | 1.39 Billion | 749.73 Million | 578.42 Million | 305.03 Million |
| Earnings Per Share Basic | 30.20 | 14.26 | 7.73 | 6.04 | 3.40 |
| Earnings Per Share Diluted | 29.26 | 14.13 | 7.71 | 6.00 | 3.40 |
| Weighted Average Shares Outstanding | 100.34 Million | 97.6 Million | 77.85 Million | 95.77 Million | 89.68 Million |
| Weighted Average Shares Outstanding (Diluted) | 103.56 Million | 98.69 Million | 78.08 Million | 96.5 Million | 89.72 Million |
| Gross Margin | 0.49 | 0.28 | 0.34 | 0.39 | 0.42 |
| EBIT Margin | 0.40 | 0.22 | 0.26 | 0.21 | 0.30 |
| Profit Margin | 0.21 | 0.13 | 0.15 | 0.32 | 0.20 |
| EBITDA | 5.73 Billion | 2.27 Billion | 1.28 Billion | 370.53 Million | 452.03 Million |
| Earnings Before Tax Margin | 0.37 | 0.19 | 0.22 | 0.13 | 0.23 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 5.02 Billion | 2.85 Billion | 3.2 Billion | 14.2 Billion | 3.07 Billion | 3.13 Billion |
| Cost of Revenue | 3.07 Billion | 1.35 Billion | 1.5 Billion | 7.2 Billion | 1.43 Billion | 1.41 Billion |
| Gross Profit | 1.95 Billion | 1.5 Billion | 1.69 Billion | 6.99 Billion | 1.64 Billion | 1.72 Billion |
| Operating Expenses | 1.2 Billion | 613.94 Million | 561.01 Million | 1.74 Billion | 425.07 Million | 377.72 Million |
| Selling, General and Administrative Expenses | 1.01 Billion | 520.42 Million | 451.58 Million | - | 362.36 Million | 307.12 Million |
| Research and Development Expenses | 196 Million | 93.52 Million | 109.42 Million | - | 62.71 Million | 70.59 Million |
| Other Expenses | 112.84 Million | 123.74 Million | -417.11 Million | -1.01 Billion | -254.67 Million | -280.95 Million |
| Cost and Expenses | 4.28 Billion | 1.96 Billion | 2.06 Billion | 8.95 Billion | 1.85 Billion | 1.79 Billion |
| Operating Income | 855.3 Million | 1.01 Billion | 718.71 Million | 4.23 Billion | 964.41 Million | 1.06 Billion |
| Interest Expense | 142.19 Million | 32.25 Million | 39.05 Million | 171.23 Million | 41.4 Million | 46.78 Million |
| Income Tax Expense | 298.18 Million | 239.87 Million | 96.58 Million | 992.22 Million | 178.26 Million | 318.2 Million |
| Earnings before Tax | 1.51 Billion | 983.54 Million | 679.65 Million | 4.06 Billion | 923.01 Million | 1.01 Billion |
| Net Income | 1.17 Billion | 716.13 Million | 565.6 Million | 3.03 Billion | 733.16 Million | 692.02 Million |
| Earnings Per Share Basic | 11.61 | 7.07 | 5.59 | - | 7.28 | 6.89 |
| Earnings Per Share Diluted | 11.26 | 6.88 | 5.36 | - | 7.14 | 6.78 |
| Weighted Average Shares Outstanding | 100.93 Million | 101.23 Million | 105.46 Million | 100.34 Million | 100.7 Million | 100.43 Million |
| Weighted Average Shares Outstanding (Diluted) | 104.06 Million | 105.04 Million | 106.72 Million | 103.56 Million | 102.68 Million | 102.02 Million |
| Gross Margin | 0.39 | 0.53 | 0.53 | 0.49 | 0.53 | 0.55 |
| EBIT Margin | 0.22 | 0.42 | 0.28 | - | 0.36 | 0.38 |
| Profit Margin | 0.23 | 0.25 | 0.18 | 0.21 | 0.24 | 0.22 |
| EBITDA | 1.1 Billion | 1.2 Billion | 902.98 Million | - | 1.11 Billion | 1.2 Billion |
| Earnings Before Tax Margin | 0.17 | 0.36 | 0.22 | 0.30 | 0.31 | 0.34 |
7022
APURE
3521
AIE
ERRIA
ANSALHSG